Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1999
03/04/1999WO1999010342A1 Antibiotic oxazolidinone derivatives
03/04/1999WO1999010340A1 Compounds possessing neuronal activity
03/04/1999WO1999010339A1 2-aminopyridines containing fused ring substituents as nos inhibitors
03/04/1999WO1999010338A2 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
03/04/1999WO1999010333A1 Dicyclanil polymorphs and hydrates and their preparation
03/04/1999WO1999010332A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
03/04/1999WO1999010330A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999WO1999010325A1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
03/04/1999WO1999010324A1 AZETIDINONE DERIVATIVES AS β-LACTAMASE INHIBITORS
03/04/1999WO1999010322A1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
03/04/1999WO1999010321A2 Antimicrobial compounds
03/04/1999WO1999010320A1 Substituted benzene compounds as antiproliferative and cholesterol lowering agents
03/04/1999WO1999010318A1 Aminophenol derivatives and their use in cosmetics
03/04/1999WO1999010313A1 N-aroylphenylalanine derivatives
03/04/1999WO1999010312A1 N-alkanoylphenylalanine derivatives
03/04/1999WO1999010308A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
03/04/1999WO1999010292A2 Robustaflavone, intermediates and analogues and method for preparation thereof
03/04/1999WO1999010022A2 Methods and compositions to prevent formation of adhesions in biological tissues
03/04/1999WO1999010010A1 Sustained-release oral preparation
03/04/1999WO1999010004A2 Regulation of muscle tissues by hedgehog-like polypeptides, and formulations and uses related thereto
03/04/1999WO1999010003A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
03/04/1999WO1999010000A1 Combined preparations for treating upper gastrointestinal tract distress
03/04/1999WO1999009999A1 Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses
03/04/1999WO1999009998A1 Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
03/04/1999WO1999009996A1 Camptothecin analogs and methods of preparation thereof
03/04/1999WO1999009994A1 Use of cycloalcane-phosphonic acid esters for treating mental disorders and depressions
03/04/1999WO1999009993A1 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
03/04/1999WO1999009992A1 Neovascularization promoters
03/04/1999WO1999009991A1 Novel amide derivatives
03/04/1999WO1999009990A1 Pharmaceutical suspension comprising nevirapine hemihydrate
03/04/1999WO1999009989A1 Pharmaceutical composition containing midazolam
03/04/1999WO1999009988A1 New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
03/04/1999WO1999009987A1 Method for treating premenstrual or late luteal phase syndrome
03/04/1999WO1999009986A1 4-aminoquinazoline derivatives
03/04/1999WO1999009985A1 Inhibitors of prenyl-protein transferase
03/04/1999WO1999009984A1 Pyrrolidine and piperidine modulators of chemokine receptor activity
03/04/1999WO1999009983A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999WO1999009982A1 Prevention of adhesions and excessive scar formation using angiogenesis inhibitors
03/04/1999WO1999009981A1 Use of phanquinone for the treatment of alzheimer's disease
03/04/1999WO1999009980A1 Method for treating pain
03/04/1999WO1999009979A1 Method for treating neuropathic pain
03/04/1999WO1999009978A1 Method for treatment of non-rheumatoid athritis
03/04/1999WO1999009976A1 Anti-first-pass effect compounds
03/04/1999WO1999009975A1 4-cyano-4-deformylsordaricin derivatives
03/04/1999WO1999009974A1 4-cyano-4-deformylsordarin derivatives
03/04/1999WO1999009973A1 Pharmacologic drug combination in vagal-induced asystole
03/04/1999WO1999009972A1 Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome
03/04/1999WO1999009971A1 Pharmacologic drug combination in vagal-induced asystole
03/04/1999WO1999009970A1 Urinary incontinence therapy
03/04/1999WO1999009969A1 Treatment of cell-mediated immune diseases
03/04/1999WO1999009968A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption
03/04/1999WO1999009967A2 Cholesterol-lowering therapy
03/04/1999WO1999009966A1 Use of beta2-adrenoceptor agonists for the manufacture of a medicament for the treatment of scoliosis
03/04/1999WO1999009965A2 Anti-inflammatory agent
03/04/1999WO1999009964A2 Pharmaceutical composition containing clindamycin and clotrimazol for treating vaginal infections
03/04/1999WO1999009959A1 Rapidly disintegrating methylcellulose tablets
03/04/1999WO1999009958A1 Rapidly disintegrating methylcellulose tablets
03/04/1999WO1999009957A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
03/04/1999WO1999009954A1 Non-steroidal antiinflammatory drug formulations for topical application to the skin
03/04/1999WO1999009845A1 Imidazoquinoxaline protein tyrosine kinase inhibitors
03/04/1999WO1999009836A1 Inhibitor and preservative formulation
03/04/1999WO1999009829A1 Method for treating pain
03/04/1999WO1999009828A1 Method for amelioration of social phobia
03/04/1999WO1999009825A1 Method of preventing neuronal death
03/04/1999WO1998056408A3 Inhibitors of microbial adherence or invasion as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
03/04/1999WO1998056407A3 Fibronectin antagonists as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
03/04/1999WO1998055606A3 Lactoferrin receptor genes of moraxella
03/04/1999WO1998055074A3 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
03/04/1999WO1998054183A3 Ergoline derivatives and their use as somatostatin receptor antagonists
03/04/1999WO1998019648A3 N-oxy-naphthalimides as antibacterial agents
03/04/1999DE19738484A1 Use of N-propanoyl-mannosamine as a medicament
03/04/1999DE19738005A1 Use of known and new bis:phosphonate compounds
03/04/1999DE19737348A1 Neue pharmazeutische Zusammensetzung New pharmaceutical composition
03/04/1999DE19737105A1 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung New tissue-specific calpain, their preparation and use
03/04/1999CA2578858A1 Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
03/04/1999CA2550132A1 Rapidly disintegrating methylcellulose tablets
03/04/1999CA2550041A1 Rapidly disintegrating methylcellulose tablets
03/04/1999CA2543223A1 Rapidly disintegrating methylcellulose tablets
03/04/1999CA2302780A1 Regulation of muscle tissues by hedgehog-like polypeptides, and formulations and uses related thereto
03/04/1999CA2302504A1 Method for treating pain
03/04/1999CA2302442A1 Method for treating neuropathic pain
03/04/1999CA2302294A1 Method for treating pain
03/04/1999CA2302023A1 Angiogenesis promoter
03/04/1999CA2301893A1 Oligosaccharide derivatives and process for producing the same
03/04/1999CA2301880A1 A method of treating cancer
03/04/1999CA2301877A1 A method of treating cancer
03/04/1999CA2301857A1 A method of treating cancer
03/04/1999CA2301821A1 Heterocyclic ketones as npy y5 antagonists
03/04/1999CA2301816A1 Mdm2-specific antisense oligonucleotides
03/04/1999CA2301815A1 New tissue-specific calpaines, their production and their use
03/04/1999CA2301780A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
03/04/1999CA2301770A1 Inhibitors of prenyl-protein transferase
03/04/1999CA2301750A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
03/04/1999CA2301661A1 Human nucleotide pyrophosphohydrolase
03/04/1999CA2301586A1 Method for treatment of non-rheumatoid arthritis
03/04/1999CA2301566A1 N-acylated lipophilic amino acid derivatives
03/04/1999CA2301549A1 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
03/04/1999CA2301523A1 Azetidinone derivatives as .beta.-lactamase inhibitors
03/04/1999CA2301519A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption
03/04/1999CA2301515A1 Optionally protected 3-hydroxymethyl carbapenems and synthesis
1 ... 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 6542 6543 6544 6545 6546 6547 6548 6549 6550 6551 ... 7860